DEC 12, 2018 7:00 AM EST

Expanding Biobanking Size and Scope to Advance Big Data Discovery

Sponsored by: Brooks Life Sciences
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Associate Staff in Dermatopathology, Cleveland Clinic Medical Director, Central Biorepository, Cleveland Clinic
    Biography
      Dr. Ko is the Medical Director of the Cleveland Clinic Central Biorepository housed within Pathology and Laboratory Medicine at the Cleveland Clinic in Cleveland, Ohio. She is also a Dermatopathologist with an interest in melanoma, Merkel cell carcinoma, and tumor immunology. She completed her BS/MD in the 6-year program at Northeast Ohio Medical University. She then completed an Internship at Cleveland Clinic in Internal Medicine, and a PhD in Immunology at Case Western Reserve University. She is boarded in Anatomic and Clinical Pathology and Dermatopathology, and received all of her training at the Cleveland Clinic.

    Abstract
    DATE:   December 12, 2018
    TIME:    07:00am PST, 10:00am EST
     
    Currently, the Cleveland Clinic Biorepository is an assembly of several biobanks together with the Lerner Research Institute. Excel spreadsheets track almost everything – and there are no universal LIS, SOPs, universal, centralized freezer monitoring, or means to electronically track patient tissue.
     
    The Cleveland Clinic is embarking on an enterprise-wide initiative to accelerate its biobanking capacity, leveraging its clinical volume and disease expertise. As part of this initiative, the Cleveland Clinic is partnering with Brooks Life Sciences to build a state of the art, 21,000 square-foot structure biobanking facility, set to open in the summer of 2019.
     
    The collaboration will partner with the community of Cleveland to advance personalized medicine for an array of conditions, and support research with clinically annotated human tissue samples. It will accelerate translational research through streamlined patient recruitment and enrollment, standardized samples processing, and centralized storage, and allow Cleveland Clinic experts and their collaborators to investigate and cure the diseases that ail our patients.
     
    In this webinar you will learn:
    • What clinical translational specimens do we have that could contribute to big data discovery?
    • What resources do you need to build an infrastructure to enhance researchers’ study of human tissue samples and advance personalized medicine for an array of conditions?
     
     

    Show Resources
    You May Also Like
    OCT 08, 2020 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    FEB 25, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 25, 2020 9:00 AM PST
    Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
    MAR 03, 2020 9:00 AM JST
    C.E. CREDITS
    MAR 03, 2020 9:00 AM JST
    DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    JUN 23, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    Loading Comments...
    Show Resources
    Attendees
    • See more